AI-enabled drug research reduces time and cost of drug development
Debiopharm invests in VeriSIM Life’s $15m series A round
12-Jan-2022 -
Debiopharm, a Swiss biopharmaceutical company, announced their co-investment in California-based start-upVeriSIM Life’s $15 Million Series A Round to advance their mission to accelerate drug development via technology powered by artificial intelligence (AI). VeriSIM Life’s computational platform ...
animal experiments
artificial intelligence
drug development
+1